[THE REACTOGENICITY AND IMMUNOLOGICAL EFFECTIVENESS OF THE NEW SORBED SOLUBLE PERTUSSIS-DIPHTHERIA-TETANUS VACCINE].
D000917:Antibody Formation; D002648:Child; D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D005334:Fever; D006801:Humans; D007223:Infant; D010567:Pertussis Vaccine; D012882:Skin Tests; D013745:Tetanus Toxoid; D014116:Toxicology; D014611:Vaccination; D014917:Whooping Cough
D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D010567:Pertussis Vaccine; D013745:Tetanus Toxoid
ANTIBODY FORMATION; CHILD; DIPHTHERIA TOXOID; FEVER; INFANT; PERTUSSIS VACCINE; SKIN TESTS; TETANUS TOXOID; TOXICOLOGIC REPORT; VACCINATION
REAKTOGENNOST' I IMMUNOLOGICHESKAIA 'EFFEKTIVNOST' NOVO I SORBIROVANNO I RASTVORIMO I KOKLIUSHNO-DIFTERIINO-STOLBNIACHNO I VAKTSINY.